About us Contact Terms of Use Data Sources Publications FAQ
GABRA2 logo

GABRA2

Gamma-aminobutyric acid receptor subunit alpha-2

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 1.44 0.02 -0.70 -0.45 -0.06 126 0.60 -0.69 -0.44 -0.25 -0.02 -0.26
Bladder (BLCA) 406 1.42 -0.75 -0.69 -0.39 -0.00 9 0.57 0.52 0.28 0.13 -0.01 -0.97
Breast (BRCA) 1067 1.88 0.27 -0.76 -0.33 -0.00 178 1.64 1.01 0.78 0.48 -0.02 -1.53
Cervical (CESC) 297 1.67 -0.75 -0.71 -0.49 -0.00 10 0.83 0.70 0.57 0.45 -0.16 -1.28
Cholangiocarcinoma (CHOL) 36 1.15 -0.76 -0.72 -0.41 -0.10 0
Colon (COAD) 443 2.32 1.31 0.84 0.43 -0.01 166 1.70 1.17 0.98 0.80 -0.09 -0.14
B-cell lymphoma (DLBC) 42 0.31 -0.72 -0.69 -0.50 -0.02 337 0.86 -0.63 -0.60 -0.32 -0.00 -0.10
Esophageal (ESCA) 142 2.16 0.55 0.18 -0.39 -0.01 271 1.14 0.34 0.16 -0.42 -0.00 0.02
Glioblastoma (GBM) 160 1.94 1.34 1.03 0.74 0.01 214 2.13 1.67 1.50 1.32 -0.09 -0.47
Head and neck (HNSC) 432 1.61 -0.73 -0.66 -0.38 -0.01 55 0.84 0.18 0.02 -0.20 -0.02 -0.68